Jane Street Group, LLC Sorrento Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$2.0 - $4.9 $263,200 - $644,840	-131,600 Reduced 61.67%	81,800 $191,000
Q4 2021 Feb 15, 2022	BUY	$4.65 - $7.23 $339,450 - $527,790	73,000 Added 51.99%	213,400 $992,000
Q3 2021 Nov 16, 2021	SELL	$7.41 - $10.99 $1.46 Million - $2.16 Million	-196,900 Reduced 58.38%	140,400 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $198,755 - $313,000	31,300 Added 10.23%	337,300 $3.27 Million
Q1 2021 May 18, 2021	SELL	$7.03 - $16.51 $457,653 - $1.07 Million	-65,100 Reduced 17.54%	306,000 $2.53 Million
Q4 2020 Feb 17, 2021	SELL	$5.76 - $11.95 $1.25 Million - $2.59 Million	-216,500 Reduced 36.84%	371,100 $2.53 Million
Q3 2020 Nov 17, 2020	SELL	$6.17 - $18.82 $704,614 - $2.15 Million	-114,200 Reduced 16.27%	587,600 $6.55 Million
Q2 2020 Aug 17, 2020	BUY	$1.73 - $6.76 $1.21 Million - $4.74 Million	701,800 New	701,800 $4.41 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.